Two High Yielders To Buy On Dismal Jobs Report

Jan. 10, 2014 10:54 AM ETMPW, DOC14 Comments

The December Jobs report was delivered prior to trading Friday. The report saw the lowest amount of job creation in three years. It is hard to sugar coat these dismal results. This could well be the beginning of yet another false start to economic recovery, which has happened all too often over the past five years.

The report showed that 74,000 new jobs were created in the month while 347,000 individuals dropped out of the workforce. The labor participation rate now stands at 62.8%, the lowest since the middle of the Carter administration. Trying to find some bright side to these disappointing results leads me to some high-yield plays.

High-yield sectors like real estate investment trusts (REITs) have underperformed the market since the Federal Reserve started to talk about the 'taper' in May. 10-year treasury yields have gone from ~1.6% to 3% over the past seven months. The 3% level has proven to provide stubborn resistance and with this poor jobs report, rates should drop further. I think this will raise the attractiveness of the REIT sector. Here are two attractive high-yield plays that I bought this morning on today's poor job results. Both REITs were upgraded by Jefferies this week as well.

Medical Properties Trust (MPW) - This unique REIT focuses almost exclusively on investing in hospitals leased under long-term net leases. MPW sells for ~$12.50 but Jefferies just put a $14 a share price target on the shares noting "the stock's valuation at 11.5x FFO and 6.7% implied cap rate makes MPW a compelling risk/reward proposition.

The REIT sold for almost $18 a share before 'taper' talk started to impact the entire REIT sector. This seems reasonable MPW could recapture a decent portion of that decline if interest rates pull back as the result of poor job gains.

This article was written by

Bret Jensen profile picture
48.98K Followers

Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech sector. Bret specializes in high beta sectors with potentially large investor returns.

Bret leads the investing group The Biotech Forum, in which he and his team offer a model portfolio with their favorite 12-20 high upside biotech stocks, live chat to discuss trade ideas, and weekly research and option trades. The group also provides market commentary and a portfolio update every weekend. Learn More.

Recommended For You

Related Stocks

SymbolLast Price% Chg
MPW--
Medical Properties Trust, Inc.
DOC--
Healthpeak Properties, Inc.

Related Analysis